Mitochondrial effects of plant-made compounds

Antioxidants and Redox Signaling

Volumn 15, Issue 12, 2011, Pages 3039-3059

  Biasutto, Lucia ^a   Szabo, Ildiko ^a   Zoratti, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CATECHIN; COPPER; CURCUMIN; ION CHANNEL; IRON; PLANT MEDICINAL PRODUCT; POLYPHENOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE;

AGING; APOPTOSIS; AUTOPHAGY; BIOGENESIS; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HORMESIS; HUMAN; INTRACELLULAR SIGNALING; MITOCHONDRIAL PERMEABILITY; MITOGENESIS; MOLECULAR DYNAMICS; NECROSIS; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; REDOX STRESS; REVIEW; UPREGULATION;

ANIMALS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; ORGANIC CHEMICALS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS;

EID: 80155167889     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4021     Document Type: Review

References (248)

1. Abramov AY, Smulders-Srinivasan TK, Kirby DM, Acin-Perez R, Enriquez JA, Lightowlers RN, Duchen MR, and Turnbull DM. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain 133: 797-807, 2010.
2. Adam-Vizi V and Starkov AA. Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J Alzheimers Dis 20 Suppl: S413-S426, 2010.
3. Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, and Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem 102: 580-592, 2007.
4. Albani D, Polito L, and Forloni G. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 19: 11-26, 2010.
5. Bae JH, Park JW, and Kwon TK. Ruthenium red, inhibitor of mitochondrial Ca2 + uniporter, inhibits curcumininduced apoptosis via the prevention of intracellular Ca2 + depletion and cytochrome c release. Biochem Biophys Res Commun 303: 1073-1079, 2003.
6. Baffy G. Uncoupling protein-2 and cancer. Mitochondrion 10: 243-252, 2010.
7. Bansal P, Paul P, Mudgal J, G Nayak P, Thomas Pannakal S, Priyadarsini KI, and Unnikrishnan MK. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/ streptozoticin-induced diabetes in mice. Exp Toxicol Pathol 2011, [Epub ahead of print]; DOI 10.1016/j.etp.2010.12.009
8. Barber SC, Higginbottom A, Mead RJ, Barber S, and Shaw PJ. An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic Biol Med 46: 1127-1138, 2009.
9. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, and Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006.
10. Benard G, Bellance N, Jose C, Melser S, Nouette-Gaulain K, and Rossignol R. Multi-site control and regulation of mitochondrial energy production. Biochim Biophys Acta 1797: 698-709, 2010.
11. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition, Physiol Rev 79: 1127-1155, 1999.
12. Bernardi P and Bonaldo P. Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies. Ann NY Acad Sci 1147: 303-311, 2008.
13. Biasutto L, Dong LF, Zoratti M, and Neuzil J. Mitochondrially targeted anti-cancer agents. Mitochondrion 10: 670-681, 2010.
14. Biasutto L, Marotta E, Bradaschia A, Fallica M, Mattarei A, Garbisa S, Zoratti M, and Paradisi C. Soluble polyphenols: synthesis and bioavailability of 3,4,5-tri(a-D-glucose-3-Osuccinyl) resveratrol. Bioorg Med Chem Lett 19: 6721-6724, 2009.
15. Bindoli A, Fukuto JM, and Forman HJ. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal 10: 1549-1564, 2008.
16. Birringer M, Lington D, Vertuani S, Manfredini S, Scharlau D, Glei M, and Ristow M. Proapoptotic effects of longchain vitamin E metabolites in HepG2 cells are mediated by oxidative stress. Free Radic Biol Med 49: 1315-1322, 2010.
17. Boots AW, Haenen GR, and Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585: 325-337, 2008.
18. Brown DA and O'Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res 88: 241-249, 2010.
19. Calabrese EJ, Mattson MP, and Calabrese V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol 29: 980-1015, 2010.
20. Cantó C and Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 67: 3407-3423, 2010.
21. Chan CS, Gertler TS, and Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32: 249-256, 2009.
22. Chang CR and Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynaminrelated protein Drp1. Ann NY Acad Sci 1201: 34-39, 2010.
23. Chen Y, Wu CM, Dai RJ, Li L, Yu YH, Li Y, Meng WW, Zhang L, Zhang Y, and Deng YL. Combination of HPLC chromatogram and hypoglycemic effect identifies isoflavones as the principal active fraction of Belamcanda chinensis leaf extract in diabetes treatment. J Chromatogr B Analyt Technol Biomed Life Sci 879: 371-378, 2011.
24. Cho DH, Nakamura T, and Lipton SA. Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 67: 3435-3447, 2010.
25. Choi SH, Kim YW, and Kim SG. AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress. Biochem Pharmacol 79: 1352-1362, 2010.
26. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, and Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501: 79-90, 2010.
27. Circu ML and Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749-762, 2010.
28. Ćzková A, Stránecký V, Mayr JA, Tesarová M, Havĺcková V, Paul J, Ivánek R, Kuss AW, Hanśková H, Kaplanová V, Vrbacký M, Hartmannová H, Nosková L, Honźk T, Drahota Z, Magner M, Hejzlarová K, Sperl W, Zeman J, Houstek J, and Kmoch S. TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat Genet 40: 1288-1290, 2008.
29. Cochemé HM and Murphy MP. Can antioxidants be effective therapeutics? Curr Opin Investig Drugs 11: 426-431, 2010.
30. Cox AG, Winterbourn CC, and Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signaling. Biochem J 425: 313-325, 2010.
31. Dai DF, Chen T, Wanagat J, Laflamme M, Marcinek DJ, Edmond MJ, Ngo CP, Prolla TA, and Rabinovitch PS. Agedependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9: 536-544, 2010.
32. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significante of S-glutathionylation. Antioxid Redox Signal 10: 445-473, 2008.
33. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, and Van der Schyf CJ. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 10: 729-745, 2010.
34. Dasgupta B and Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 104: 7217-7222, 2007.
35. David KK, Andrabi SA, Dawson TM, and Dawson VL. Parthanatos, a messenger of death. Front Biosci 14: 1116-1128, 2009.
36. Davis JM, Murphy EA, Carmichael MD, and Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296: R1071-R1077, 2009.
37. de Brito OM and Scorrano L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J 29: 2715-2723, 2010.
38. Devika PT and Stanely Mainzen Prince P. (-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study. Pharmacol Res 57: 351-357, 2008.
39. Di Lisa F, Kaludercic N, Carpi A, Menabò R, and Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol 104: 131-139, 2009.
40. Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Maŕn- Hernández A, Hernández-Esquivel L, Rodŕguez-Enŕquez S, Stursa J, Witting PK, Stantic B, Rohlena J, Truksa J, Kluckova K, Dyason JC, Ledvina M, Salvatore BA, Moreno-Sánchez R, Coster MJ, Ralph SJ, Smith RA, and Neuzil J. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity. J Biol Chem 286: 3717-3728, 2011.
41. Dong LF, Low P, Dyason JC, Wang XF, Prochazka L, Witting PK, Freeman R, Swettenham E, Valis K, Liu J, Zobalova R, Turanek J, Spitz DR, Domann FE, Scheffler IE, Ralph SJ, and Neuzil J. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 27: 4324-4335, 2008.
42. Dong LF, Swettenham E, Eliasson J, Wang XF, Gold M, Medunic Y, Stantic M, Low P, Prochazka L, Witting PK, Turanek J, Akporiaye ET, Ralph SJ, and Neuzil J. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 67: 11906-11913, 2007.
43. Dudley J, Das S, Mukherjee S, and Das DK. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 20: 443-452, 2009.
44. Emerling BM, Weinberg F, Snyder C, Burgess Z, Mutlu GM, Viollet B, Budinger GR, and Chandel NS. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 46: 1386-1391, 2009.
45. Feng Z, Liu Z, Li X, Jia H, Sun L, Tian C, Jia L, and Liu J. A-Tocopherol is an effective phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem 21: 1222-1231, 2010.
46. Forester SC and Waterhouse AL. Metabolites are key to understanding health effects of wine polyphenolics. J Nutr 139: 1824S-1831S, 2009.
47. Formentini L, Mart́nez-Reyes I, and Cuezva JM. The mitochondrial bioenergetic capacity of carcinomas. IUBMB Life 62: 554-560, 2010.
48. Frässdorf J, Huhn R, Niersmann C, Weber NC, Schlack W, Preckel B, and Hollmann MW. Morphine induces preconditioning via activation of mitochondrial K(Ca) channels. Can J Anaesth 57: 767-773, 2010.
49. Frederick RL and Shaw JM. Moving mitochondria: establishing distribution of an essential organelle. Traffic 8: 1668-1675, 2007.
50. Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med 76: 1075-1079, 2010.
51. Galluzzi L, Larochette N, Zamzami N, and Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25: 4812-4830, 2006.
52. Ghibelli L and Diederich M. Multistep and multitask Bax activation. Mitochondrion 10: 604-613, 2010.
53. Gibson GE, Starkov A, Blass JP, Ratan RR, and Beal MF. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 1802: 122-134, 2010.
54. Gibson SB. A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy 6: 835-837, 2010.
55. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, and Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005.
56. Giudice A, Arra C, and Turco MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 647: 37-74, 2010.
57. Gledhill JR, Montgomery MG, Leslie AG, and Walker JE. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci USA 104: 13632-13637, 2007.
58. Gogvadze V, Orrenius S, and Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18: 165-173, 2008.
59. Gomes LC and Scorrano L. High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochim Biophys Acta 1777: 860-866, 2008.
60. Green DR and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305: 626-629, 2004.
61. Grimm S, Höhn A, and Grune T. Oxidative protein damage and the proteasome. Amino Acids 2011, [Epub ahead of print]; DOI. 10.1007/s00726-010- 0646-8
62. Guha P, Dey A, Dhyani MV, Sen R, Chatterjee M, Chattopadhyay S, and Bandyopadhyay SK. Calpain and caspase orchestrated death signal to accomplish apoptosis induced by resveratrol and its novel analog hydroxystilbene-1 in cancer cells. J Pharmacol Exp Ther 334: 381-394, 2010.
63. Gupta SC, Kim JH, Prasad S, and Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29: 405-434, 2010.
64. Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M, Popescu LM, and Das DK. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res 86: 103-112, 2010.
65. Halestrap AP and Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 1787: 1402-1415, 2009.
66. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 476: 107-112, 2008.
67. Hao J, Shen W, Yu G, Jia H, Li X, Feng Z, Wang Y, Weber P, Wertz K, Sharman E, and Liu J. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem 21: 634-644, 2010.
68. Harikumar KB and Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7: 1020-1035, 2008.
69. Harman D. The free radical theory of aging. Antioxid Redox Signal 5: 557-561, 2003.
70. Hausenloy DJ, Ong SB, and Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104: 189-202, 2009.
71. Hiona A, Sanz A, Kujoth GC, Pamplona R, Seo AY, Hofer T, Someya S, Miyakawa T, Nakayama C, Samhan-Arias AK, Servais S, Barger JL, Portero-Ot́n M, Tanokura M, Prolla TA, and Leeuwenburgh C. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One 5: e11468, 2010.
72. Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, and Burman AC. Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9: 138-161, 2009.
73. Hom J, Yu T, Yoon Y, Porter G, and Sheu SS. Regulation of mitochondrial fission by intracellular Ca2 + in rat ventricular myocytes. Biochim Biophys Acta 1797: 913-921, 2010.
74. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, and Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196, 2003.
75. Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T, and Sato Y. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci 100: 349-356, 2009.
76. Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, and Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O- gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 16: 1451-1462, 2009.
77. Jamison JM, Gilloteaux J, Taper HS, Calderon PB, and Summers JL. Autoschizis: a novel cell death. Biochem Pharmacol 63: 1773-1783, 2002.
78. Jezek P, Plecitá-Hlavatá L, Smolková K, and Rossignol R. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Int J Biochem Cell Biol 42: 604-622, 2010.
79. Jia YL, Li J, Qin ZH, and Liang ZQ. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 11: 918-928, 2009.
80. Jin F, Wu Q, Lu YF, Gong QH, and Shi JS. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600: 78-82, 2008.
81. Jitrapakdee S, Wutthisathapornchai A, Wallace JC, and MacDonald MJ. Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia 53: 1019-1032, 2010.
82. Jung HS and Lee MS. Role of autophagy in diabetes and mitochondria. Ann NY Acad Sci 1201: 79-83, 2010.
83. Kaneto H, Katakami N, Matsuhisa M, and Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010: 453892, 2010.
84. Karbowski M. Mitochondria on guard: role of mitochondrial fusion and fission in the regulation of apoptosis. Adv Exp Med Biol 687: 131-142, 2010.
85. Katoh I, Tomimori Y, Ikawa Y, and Kurata S. Dimerization and processing of procaspase-9 by redox stress in mitochondria. J Biol Chem 279: 15515-15523, 2004.
86. Kenealey JD, Subramanian L, van Ginkel P, Darjatmoko S, Lindstrom M, Somoza V, Ghosh S, Song Z, Hsung R, Kwon GS, Eliceiri K, Albert D, and Polans A. Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. J Agric Food Chem 59: 4979-4986, 2011.
87. Khan N, Adhami VM, and Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer 17: R39-R52, 2010.
88. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, and Tsai LH. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26: 3169-3179, 2007.
89. Kim I, Rodriguez-Enriquez S, and Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245-253, 2007.
90. Kim J, Lee HJ, and Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 112: 1415-1430, 2010.
91. Kim YW, Lee SM, Shin SM, Hwang SJ, Brooks JS, Kang HE, Lee MG, Kim SC, and Kim SG. Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radic Biol Med 47: 1082-1092, 2009.
92. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, and Pedersen PL. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 324: 269-275, 2004.
93. Kowaltowski AJ, Castilho RF, and Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 495: 12-15, 2001.
94. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, and Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484, 2005.
95. Kumar P, Padi SS, Naidu PS, and Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17: 485-492, 2006.
96. Kundu JK and Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269: 243-261, 2008.
97. Kuo YF, Su YZ, Tseng YH, Wang SY, Wang HM, and Chueh PJ. Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. Free Radic Biol Med 49: 214-226, 2010.
98. Kurz T, Eaton JW, and Brunk UT. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid Redox Signal 13: 511-523, 2010.
99. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127: 1109-1122, 2006.
100. Lambert JD and Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65-72, 2010.
101. Lambert JD, Sang S, and Yang CS. Biotransformation of gree tea polyphenols and the biological activities of those metabolites. Mol Pharm 4: 819-825, 2007.
102. Lapointe J and Hekimi S. When a theory of aging ages badly. Cell Mol Life Sci 67: 1-8, 2010.
103. Larrieu S, Letenneur L, Helmer C, Dartigues JF, and Barberger-Gateau P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging 8: 150-154, 2004.
104. Larsen CA, Dashwood RH, and Bisson WH. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance. Pharmacol Res 62: 457-464, 2010.
105. Larsson NG. Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 79: 683-706, 2010.
106. Lee-Hilz YY, Boerboom AM, Westphal AH, Berkel WJ, Aarts JM, and Rietjens IM. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol 19: 1499-1505, 2006.
107. Leibowitz G, Bachar E, Shaked M, Sinai A, Ketzinel-Gilad M, Cerasi E, and Kaiser N. Glucose regulation of b-cell stress in type 2 diabetes. Diabetes Obes Metab 12 Suppl 2: 66-75, 2010.
108. Leonarduzzi G, Testa G, Sottero B, Gamba P, and Poli G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr Med Chem 17: 74-95, 2010.
109. Levine B, Mizushima N, and Virgin HW. Autophagy in immunity and inflammation. Nature 469: 323-335, 2011.
110. Li G, He S, Chang L, Lu H, Zhang H, Zhang H, and Chiu J. GADD45a and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. Phytomedicine 18: 704-709, 2011.
111. Liang HL, Dhar SS, and Wong-Riley MT. p38 mitogenactivated protein kinase and calcium channels mediate signaling in depolarization-induced activation of peroxisome proliferator-activated receptor gamma coactivator-1a in neurons. J Neurosci Res 88: 640-649, 2010.
112. Lin HY, Tang HY, Davis FB, and Davis PJ. Resveratrol and apoptosis. Ann NY Acad Sci 1215: 79-88, 2011.
113. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006.
114. Lira VA, Benton CR, Yan Z, and Bonen A. PGC-1a regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 299: E145-E161, 2010.
115. Liu EH, Qi LW, Wu Q, Peng YB, and Li P. Anticancer agents derived from natural products. Mini Rev Med Chem 9: 1547-1555, 2009.
116. López-Lázaro M. A new view of carcinogenesis and an alternative approach to cancer therapy. Mol Med 16: 144-153, 2010.
117. Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, Chiou RY, Wung BS, Peng CH, and Yang YL. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56: 6910-6913, 2008.
118. Lu YX, Zhang Q, Li J, Sun YX, Wang LY, Cheng WM, and Hu XY. Antidiabetic effects of total flavonoids from Litsea Coreana leaf on fat-fed, streptozoticin-induced type 2 diabetic rats. Am J Chin Med 38: 713-725, 2010.
119. Madeo F, Tavernarakis N, and Kroemer G. Can autophagy promote longevity? Nat Cell Biol 12: 842-846, 2010.
120. Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, and Krupitza G. Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102: 1361-1370, 2010.
121. Manach C, Williamson G, Morand C, Scalbert A, and Ré-mésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (1 Suppl): 230S-242S, 2005.
122. Mandel S, Amit T, Reznichenko L, Weinreb O, and Youdim MB. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res 50: 229-234, 2006.
123. Marambaud P, Zhao H, and Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280: 37377-37382, 2005.
124. Maŕ M, Morales A, Colell A, Garća-Ruiz C, and Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700, 2009.
125. Martin A, Joseph JA, and Cuervo AM. Stimulatory effect of vitamin C on autophagy in glial cells. J Neurochem 82: 538-549, 2002.
126. Martinez-Caballero S, Dejean LM, Kinnally MS, Oh KJ, Mannella CA, and Kinnally KW. Assembly of the mitochondrial apoptosis-induced channel, MAC. J Biol Chem 284: 12235-12245, 2009.
127. Marzetti E, Lees HA, Wohlgemuth SE, and Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35: 28-35, 2009.
128. Mathupala SP, Ko YH, and Pedersen PL. The pivotal roles of mitochondria in cancer: warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta 1797: 1225-1230, 2010.
129. Mattson MP. Dietary factors, hormesis and health. Ageing Res Rev 7: 43-48, 2008.
130. Mehta RG and Pezzuto JM. Discovery of cancer preventive agents from natural products: from plants to prevention. Curr Oncol Rep 4: 478-486, 2002.
131. Michelakis ED, Webster L, and Mackey JR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 99: 989-994, 2008.
132. Misko A, Jiang S, Wegorzewska I, Milbrandt J, and Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 30: 4232-4240, 2010.
133. Montero M, Lobatón CD, Hernández-Sanmiguel E, Santodomingo J, Vay L, Moreno A, and Alvarez J. Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids. Biochem J 384: 19-24, 2004.
134. Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, and Jaeger W. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261: 172-182, 2008.
135. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
136. Nakazato T, Ito K, Ikeda Y, and Kizaki M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res 11: 6040-6049, 2005.
137. Nardi A, Calderone V, Chericoni S, and Morelli I. Natural modulators of large-conductance calcium-activated potassium channels. Planta Med 69: 885-892, 2003.
138. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, and Marber MS. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 103: 307-314, 2008.
139. Nishiyama S, Shitara H, Nakada K, Ono T, Sato A, Suzuki H, Ogawa T, Masaki H, Hayashi J, and Yonekawa H. Overexpression of TFAM improves the mitochondrial disease phenotypes in a mouse model system. Biochem Biophys Res Commun 401: 26-31, 2010.
140. Norberg E, Gogvadze V, Ott M, Horn M, Uhlén P, Orrenius S, and Zhivotovsky B. An increase in intracellular Ca2 + is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ 15: 1857-1864, 2008.
141. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 24: 1311-1317, 2005.
142. Orrenius S, Nicotera P, and Zhivotovsky B. Cell death mechanisms and their implications in toxicology. Toxicol Sci 119: 3-19, 2011.
143. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, and Ahn K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285: 8340-8351, 2010.
144. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, and Mootha VK. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123, 2008.
145. Parsons MJ and Green DR. Mitochondria in cell death. Essays Biochem 47: 99-114, 2010.
146. Pavese JM, Farmer RL, and Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29: 465-482, 2010.
147. Pedersen A, Karlsson GB, and Rydström J. Protontranslocating transhydrogenase: an update of unsolved and controversial issues. J Bioenerg Biomembr 40: 463-473, 2008.
148. Pellegrini L and Scorrano L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ 14: 1275-1284, 2007.
149. Pérez VI, Bokov A, Van Remmen H, Mele J, Ran Q, Ikeno Y, and Richardson A. Is the oxidative stress theory of aging dead? Biochim Biophys Acta 1790: 1005-1014, 2009.
150. Pérez VI, Van Remmen H, Bokov A, Epstein CJ, Vijg J, and Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 8: 73-75, 2009.
151. Perron NR and Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53: 75-100, 2009.
152. Petrovsky G, Gurusamy N, and Das K. Resveratrol in cardiovascular health and disease. Ann NY Acad Sci 1215: 22-33, 2011.
153. Possemiers S, Bolca S, Verstraete W, and Heyrick A. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 82: 53-66, 2011.
154. Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, and Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med 76: 1044-1063, 2010.
155. Psahoulia FH, Moumtzi S, Roberts ML, Sasazuki T, Shirasawa S, and Pintzas A. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 28: 1021-1031, 2007.
156. Punithavathi VR and Prince PS. Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sci 86: 178-184, 2010.
157. Raffaello A and Rizzuto R. Mitochondrial longevity pathways. Biochim Biophys Acta 1813: 260-268, 2011.
158. Ralph SJ and Neuzil J. Mitochondria as targets for cancer therapy. Mol Nutr Food Res 53: 9-28, 2009.
159. Ralph SJ, Rodŕguez-Enŕquez S, Neuzil J, and Moreno-Sánchez R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 31: 29-59, 2010.
160. Ralph SJ, Rodŕguez-Enŕquez S, Neuzil J, Saavedra E, and Moreno-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med 31: 145-170, 2010.
161. Rasbach KA and Schnellmann RG. Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 325: 536-543, 2008.
162. Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, and Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 107: 726-731, 2010.
163. Rasola A, Sciacovelli M, Pantic B, and Bernardi P. Signal transduction to the permeability transition pore. FEBS Lett 584: 1989-1996, 2010.
164. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, and Perez-Pinzon MA. Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15: 1545-1551, 2008.
165. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, and Rubinsztein DC. Regulation of Mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435, 2010.
166. Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, and Monti JP. Neuroprotective properties of resveratrol and derivatives. Ann NY Acad Sci 1215: 103-108, 2011.
167. Rigoulet M, Youboue ED, and Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxid Redox Signal 14: 459-468, 2011.
168. Ristow M and Zarse K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 45: 410-418, 2010.
169. Rizzuto R, Marchi S, Bonora M, Aguiari P, Bononi A, De Stefani D, Giorgi C, Leo S, Rimessi A, Siviero R, Zecchini E, and Pinton P. Ca2 + transfer from the ER to mitochondria: when, how and why. Biochim Biophys Acta 1787: 1342-1351, 2009.
170. Robb EL, Winkelmolen L, Visanji N, Brotchie J, and Stuart JA. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem Biophys Res Commun 372: 254-259, 2008.
171. Robinson NJ and Winge DR. Copper metallochaperones. Annu Rev Biochem 79: 537-562, 2010.
172. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, Milan G, Masiero E, Del Piccolo P, Foretz M, Scorrano L, Rudolf R, and Sandri M. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 29: 1774-1785, 2010.
173. Roy SS, Ehrlich AM, Craigen WJ, and Hajnóczky G. VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep 10: 1341-1347, 2009.
174. Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, Kujoth GC, Prolla TA, and Tarnopolsky MA. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci USA 108: 4135-4140, 2011.
175. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813: 1269-1278, 2011.
176. Scherz-Shouval R and Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36: 30-38, 2011.
177. Schon EA, DiMauro S, Hirano M, and Gilkerson RW. Therapeutic prospects for mitochondrial disease. Trends Mol Med 16: 268-276, 2010.
178. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, Harbison RA, and Linseman DA. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 11: 469-480, 2009.
179. Schug ZT and Gottlieb E. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 1788: 2022-2031, 2009.
180. Scorrano L. Opening the doors to cytochrome c: changes in mitochondrial shape and apoptosis. Int J Biochem Cell Biol 41: 1875-1883, 2009.
181. Shakibaei M, Harikumar KB, and Aggarwal BB. Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53: 115-128, 2009.
182. Shanmugam MK, Kannaiyan R, and Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 63: 161-173, 2011.
183. Shin SM, Cho IJ, and Kim SG. Resveratrol protects mitochondria against oxidative stress trough AMP-activated protein kinase-mediated glycogen synthase kinase-3b inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol Pharmacol 76: 884-895, 2009.
184. Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, and Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31: 227-285, 2010.
185. Shu L, Cheung KL, Khor TO, Chen C, and Kong AN. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev 29: 483-502, 2010.
186. Siddiqui IA, Adhami VM, Ahmad N, and Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer 62: 883-890, 2010.
187. Siow RC and Mann GE. Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol Aspects Med 31: 468-477, 2010.
188. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhinsky LS, and Zorov DB. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 1787: 437-461, 2009.
189. Smith WW, Norton DD, Gorospe M, Jiang H, Nemoto S, Holbrook NJ, Finkel T, and Kusiak JW. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J Cell Biol 169: 331-339, 2005.
190. Song DK, Jang Y, Kim JH, Chun KJ, Lee D, and Xu Z. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts. J Korean Med Sci 25: 380-386, 2010.
191. Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, and Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis 31: 1424-1433, 2010.
192. Sun AY, Wang Q, Simonyi A, and Sun GY. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41: 375-383, 2010.
193. Szabadkai G, Simoni AM, Chami M, Wieckowski MR, Youle RJ, and Rizzuto R. Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2 + waves and protects against Ca2 +-mediated apoptosis. Mol Cell 16: 59-68, 2004.
194. Szabó I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, Zoratti M, and Gulbins E Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci USA 105: 14861-14866, 2008.
195. Szabò I, Soddemann M, Leanza L, Zoratti M, and Gulbins E. Single-point mutations of a lysine residue change function of Bax and Bcl-x(L) expressed in Bax-and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ 18: 427-438, 2011.
196. Szewczyk A, Jarmuszkiewicz W, and Kuncz WS. Mitochondrial potassium channels. IUBMB Life 61: 134-143, 2009.
197. Szkudelski T and Szkudelska K. Anti-diabetic effects of resveratrol. Ann NY Acad Sci 1215: 34-39, 2011.
198. Takeda K, Naguro I, Nishitoh H, Matsuzawa A, and Ichijo H. Apoptosis signaling kinases: from stress response to health outcome. Antioxid Redox Signal 2011, [Epub ahead of print]; DOI 10.1089/ars.2010.3392.
199. Tang S, Le PK, Tse S, Wallace DC, and Huang T. Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS One 4: e4492, 2009.
200. Trachootham D, Alexandre J, and Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-591, 2009.
201. Trifunovic A. Mitochondrial DNA and ageing. Biochim Biophys Acta 1757: 611-617, 2006.
202. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, and Larsson NG. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 102: 17993-17998, 2005.
203. Trifunovic A and Larsson NG. Mitochondrial dysfunction as a cause of ageing. J Intern Med 263: 167-178, 2008.
204. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlöf S, Oldfors A, Wibom R, Törnell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004.
205. Trinei M, Berniakovich I, Beltrami E, Migliaccio E, Fassina A, Pelicci P, and Giorgio M. P66Shc signals to age. Aging (Albany NY) 1: 503-510, 2009.
206. Tuppen HA, Blakely EL, Turnbull DM, and Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797: 113-128, 2010.
207. Valgimigli L and Iori R. Antioxidant and pro-oxidant capacities of ITCs. Environ Mol Mutagen 50: 222-237, 2009.
208. Vandenabeele P, Galluzzi L, Vanden Berghe T, and Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714, 2010.
209. Vanden Berghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, Guerin CJ, Brunk UT, Declercq W, and Vandenabeele P. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 17: 922-930, 2010.
210. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, and Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16: 29-37, 2003.
211. Verschoor ML, Wilson LA, and Singh G. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 88: 204-219, 2010.
212. Viña J, Gomez-Cabrera MC, Borras C, Froio T, Sanchis-Gomar F, Martinez-Bello VE, and Pallardo FV. Mitochondrial biogenesis in exercise and ageing. Adv Drug Deliv Rev 61: 1369-1374, 2009.
213. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, and Marambaud P. AMP-activated protein kinase signalling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 285: 9100-9113, 2010.
214. Vlachodimitropoulou E, Sharp PA, and Naftalin RJ. Quercetin-iron chelates are transported via Glucose (GLUT) transporters. Free Radic Biol Med 50: 934-944, 2011.
215. Wallace DC. Mouse models for mitochondrial disease. Am J Med Genet 106: 71-93, 2001.
216. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 51: 440-450, 2010.
217. Wallace DC, Fan W, and Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 5: 297-348, 2010.
218. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med 36: 829-837, 2004.
219. Walle T. Bioavailability of resveratrol. Ann NY Acad Sci 1215: 9-15, 2011.
220. Wang C and Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet 43: 95-118, 2009.
221. Wang J and Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7: 1875-1884, 2008.
222. Wenz T, Diaz F, Spiegelman BM, and Moraes CT. Activation of the PPAR/PGC-1a pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8: 249-256, 2008.
223. White E, Karp C, Strohecker AM, Guo Y, and Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 22: 212-217, 2010.
224. Wiederkehr A, and Wollheim CB. Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic b-cell. Cell Calcium 44: 64-76, 2008.
225. Williamson G, Barron D, Shimoi K, and Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 39: 457-469, 2005.
226. Wojcik M, Burzynska-Pedziwiatr I, and Wozniak LA. A review of natural and synthetic antioxidants important for health and longevity. Curr Med Chem 17: 3262-3288, 2010.
227. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11: 3013-3069, 2009.
228. Wong E and Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 805-811, 2010.
229. Wu S, Zhou F, Zhang Z, and Xing D. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 278: 941-954, 2011.
230. Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, Lu CC, Yang JL, Lai TY, Ko YC, and Chung JG. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res 30: 2125-2133, 2010.
231. Xu ZX, Liang J, Haridas V, Gaikwad A, Connolly FP, Mills GB, and Gutterman JU. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ 14: 1948-1957, 2007.
232. Yamashima T and Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 89: 343-358, 2009.
233. Yan F, Cao XX, Jiang HX, Zhao XL, Wang JY, Lin YH, Liu QL, Zhang C, Jiang B, and Guo F. A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer. J Med Chem 53: 5502-5510, 2010.
234. Yang Z and Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822, 2010.
235. Ye H and Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49: 4945-4956, 2010.
236. Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, and Elledge SJ. Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev 24: 1507-1518, 2010.
237. Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, Bataille D, and Oiry C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic b-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 161: 799-814, 2010.
238. Youle RJ and Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14, 2011.
239. Yu S, Zheng W, Xin N, Chi ZH, Wang NQ, Nie YX, Feng WY, and Wang ZY. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 13: 55-64, 2010.
240. Yu W, Tiwary R, Li J, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, and Kline K. A-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Mol Carcinog 49: 964-973, 2010.
241. Zhang D, Mott JL, Chang SW, Denniger G, Feng Z, and Zassenhaus HP. Construction of transgenic mice with tissuespecific acceleration of mitochondrial DNA mutagenesis. Genomics 69: 151-161, 2000.
242. Zhu J and Chu CT. Mitochondrial dysfunction in Parkinson's disease. J Alzheimers Dis 20 Suppl 2: S325-S334, 2010.
243. Zhu L, Liu Z, Feng Z, Hao J, Shen W, Li X, Sun L, Sharman E, Wang Y, Wertz K, Weber P, Shi X, and Liu J. Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells. J Nutr Biochem 21: 1089-1098, 2010.
244. Zini R, Morin C, Bertelli A, Bertelli AA, and Tillement JP. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res 25: 87-97, 1999.
245. Ziviani E, Tao RN, and Whitworth AJ. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci USA 107: 5018-5023, 2010.
246. Zoratti M, De Marchi U, Gulbins E, and Szabò I. Novel channels of the inner mitochondrial membrane. Biochim Biophys Acta Bioenerg 1787: 351-363, 2009.
247. Zoratti M, De Marchi U, Biasutto L, and Szabò I. Electrophysiology clarifies the megariddles of the mitochondrial permeability transition pore. FEBS Lett 584: 1997-2004, 2010.
248. Zygmunt K, Faubert B, MacNeil J, and Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem Biophys Res Commun 398: 178-183, 2010.